UBS lowered the firm’s price target on Community Health (CYH) to $3.50 from $4.10 and keeps a Neutral rating on the shares. Community Health reported “solid” quarterly results, and there was a positive reaction to the debt refinancing, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYH: